New hope for Tough-to-Treat depression

NCT ID NCT06911112

Recruiting now Disease control Sponsor: Neurocrine Biosciences Source: ClinicalTrials.gov ↗

Summary

This study is testing whether adding a new investigational drug, called NBI-1065845, to a person's current antidepressant medication can help reduce symptoms of major depression. It is for adults who are still struggling with moderate to severe depression despite taking standard antidepressant pills. Participants will take either the new drug or a placebo (a pill with no medicine) for 8 weeks, in addition to their regular medication, to see if it makes a difference.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Neurocrine Clinical Site
RECRUITING

Huntsville, Alabama, 35801, United States
Neurocrine Clinical Site
RECRUITING

Glendale, California, 91206, United States
Neurocrine Clinical Site
RECRUITING

Irvine, California, 92614, United States
Neurocrine Clinical Site
RECRUITING

Miami, Florida, 33174, United States
Neurocrine Clinical Site
RECRUITING

Tampa, Florida, 33607, United States
Neurocrine Clinical Site
RECRUITING

Atlanta, Georgia, 30318, United States
Neurocrine Clinical Site
RECRUITING

Boston, Massachusetts, 02131, United States
Neurocrine Clinical Site
RECRUITING

Saint Charles, Missouri, 63304, United States
Neurocrine Clinical Site
RECRUITING

The Bronx, New York, 10461, United States
Neurocrine Clinical Site
RECRUITING

Mason, Ohio, 45040, United States

Conditions

Explore the condition pages connected to this study.

MAJOR DEPRESSIVE DISORDER